Jeffrey Paley - 07 Nov 2023 Form 4 Insider Report for Journey Medical Corp (DERM)

Role
Director
Signature
/s/ Ramsey Alloush, attorney-in-fact
Issuer symbol
DERM
Transactions as of
07 Nov 2023
Net transactions value
-$8,771
Form type
4
Filing time
08 Dec 2023, 17:01:18 UTC
Previous filing
10 Oct 2023
Next filing
29 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, par value $0.0001 per share Sale $7,813 -2,245 -1.9% $3.48 114,472 07 Nov 2023 Direct F1
transaction DERM Common Stock, par value $0.0001 per share Sale $959 -255 -0.22% $3.76 114,217 08 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jeffrey Paley is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reporting person realized short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of sales of the Issuer's common stock reported herein, as well as the sales reported on a Form 4 filed November 29, 2023, being matched against non-exempt purchases of 4,245 shares of common stock made on September 21, 2023. Accordingly, the reporting person has paid to the Issuer (i) $1,724.98 in connection with the matched sales reported herein and (ii) $4,189.95 in connection with the matched sales made on November 28, 2023, representing the aggregate short-swing profit realized by the reporting person, less transaction costs. Includes 10,000 restricted units of which will vest in full on July 1, 2024 and 27,472 restricted stock units of which will vest on July 21, 2024.